SynthesisFrontiers in medicine2026
Exercise dose and modality for blood pressure reduction in predominantly postmenopausal women: a dose-response network meta-analysis.
Synthesis in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Blood pressure rises during the menopausal transition and postmenopause, yet exercise guidance seldom specifies the type and dose most effective for lowering it. We examined the dose-response relationship between exercise and blood pressure in trials enrolling peri- or postmenopausal women, while recognizing that the available evidence was predominantly derived from postmenopausal populations. Methods: We searched PubMed, Web of Science, Embase, and the Cochrane CENTRAL register from inception to March 2026 for randomized controlled trials of exercise interventions lasting at least 4 weeks in peri- or postmenopausal women. To limit dose misclassification, weekly dose was derived only from trials that reported exercise frequency, intensity, and session duration, expressed as METs-min/week and adjusted for attendance where this was reported. A Bayesian model-based dose-response network meta-analysis was fitted, with risk of bias assessed using RoB 2 and certainty of evidence using CINeMA. Results: Seventy-four trials involving 3,573 women (mean age, 59.5 years) were included; 70 exclusively enrolled postmenopausal women and four included perimenopausal women. Among eight candidate dose-response functions, the quadratic model yielded the lowest DIC and was retained as the primary model. Under this model, the largest predicted reductions occurred at 1,400 METs-min/week for SBP (-6.70 mmHg, 95% credible interval -9.18 to -4.29) and 1,500 METs-min/week for DBP (-4.20 mmHg, -6.52 to -1.74). The apparent attenuation at higher doses was model-dependent. At the highest observed AQE dose of 800 METs-min/week, aquatic exercise produced the largest model-estimated point reductions for both outcomes (systolic -11.63 mmHg; diastolic -7.73 mmHg); however, these estimates were based on only three AQE intervention arms and the ranking should be considered exploratory. Meta-regression found no significant moderation by age, baseline blood pressure, or intervention length. Certainty of evidence ranged from very low to low. Conclusion: Among trial populations composed predominantly of postmenopausal women, exercise was associated with a non-linear, dose-related reduction in blood pressure. The largest model-estimated reductions occurred near 1,400-1,500 METs-min/week. Aquatic exercise appeared promising, but the small number of contributing trials and the generally low certainty of evidence preclude definitive modality ranking. Evidence remains insufficient to draw stage-specific conclusions for perimenopausal women. Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier [CRD420261354599].
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.